TNNT3
Basic information
Region (hg38): 11:1919703-1938706
Links
Phenotypes
GenCC
Source:
- digitotalar dysmorphism (Supportive), mode of inheritance: AD
- Sheldon-hall syndrome (Supportive), mode of inheritance: AD
- arthrogryposis, distal, type 2B2 (Moderate), mode of inheritance: AD
- nemaline myopathy (Moderate), mode of inheritance: AR
- distal arthrogryposis type 2B1 (Strong), mode of inheritance: AD
- nemaline myopathy (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Arthyrgryposis, distal, type 2B2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 12865991 |
ClinVar
This is a list of variants' phenotypes submitted to
- Arthrogryposis, distal, type 2B2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNNT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 24 | ||||
missense | 61 | 67 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 8 | 9 | 2 | 19 | ||
non coding | 50 | 45 | 101 | |||
Total | 1 | 3 | 77 | 74 | 49 |
Variants in TNNT3
This is a list of pathogenic ClinVar variants found in the TNNT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-1919759-G-T | Distal arthrogryposis type 2B1 • Arthrogryposis multiplex congenita distal | Uncertain significance (Jan 12, 2018) | ||
11-1922375-G-A | not provided (Mar 18, 2012) | |||
11-1922478-C-A | not provided (Mar 18, 2012) | |||
11-1922639-C-T | Benign (Oct 28, 2019) | |||
11-1922820-C-CCT | Benign (Apr 28, 2020) | |||
11-1922882-A-T | Benign (Dec 22, 2023) | |||
11-1922885-A-T | Uncertain significance (Sep 09, 2023) | |||
11-1922887-G-A | Uncertain significance (Jun 17, 2021) | |||
11-1922972-A-G | Arthrogryposis, distal, type 2B2 | Benign (Jul 14, 2021) | ||
11-1923040-C-A | Likely benign (Sep 19, 2023) | |||
11-1923047-G-T | Uncertain significance (Sep 27, 2022) | |||
11-1923076-C-G | Likely benign (Jul 06, 2022) | |||
11-1923406-A-T | Arthrogryposis, distal, type 2B2 | Benign (Jul 14, 2021) | ||
11-1923544-TC-AA | Uncertain significance (Sep 09, 2023) | |||
11-1923552-C-T | Uncertain significance (Oct 19, 2023) | |||
11-1923557-C-A | Uncertain significance (Jun 17, 2021) | |||
11-1923560-T-C | Arthrogryposis, distal, type 2B2 | Uncertain significance (-) | ||
11-1923562-C-A | Uncertain significance (Apr 24, 2022) | |||
11-1923562-C-T | Likely benign (Dec 09, 2023) | |||
11-1923562-CGAA-C | Likely benign (Oct 04, 2023) | |||
11-1923564-A-G | Uncertain significance (Sep 09, 2023) | |||
11-1923589-C-T | Likely benign (Nov 22, 2023) | |||
11-1923590-C-T | Likely benign (Oct 04, 2023) | |||
11-1923591-G-A | Likely benign (Mar 23, 2023) | |||
11-1923624-C-A | Likely benign (Nov 14, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNNT3 | protein_coding | protein_coding | ENST00000278317 | 15 | 19145 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.08e-7 | 0.891 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.463 | 130 | 146 | 0.892 | 0.00000999 | 1723 |
Missense in Polyphen | 47 | 54.678 | 0.85958 | 658 | ||
Synonymous | -0.644 | 57 | 51.1 | 1.11 | 0.00000356 | 412 |
Loss of Function | 1.65 | 14 | 22.4 | 0.624 | 0.00000121 | 279 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000400 | 0.000397 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000709 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000198 | 0.000196 |
Other | 0.000169 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity.;
- Pathway
- Disopyramide Action Pathway;Procainamide (Antiarrhythmic) Action Pathway;Phenytoin (Antiarrhythmic) Action Pathway;Fosphenytoin (Antiarrhythmic) Action Pathway;Bopindolol Action Pathway;Timolol Action Pathway;Carteolol Action Pathway;Bevantolol Action Pathway;Practolol Action Pathway;Dobutamine Action Pathway;Isoprenaline Action Pathway;Arbutamine Action Pathway;Amiodarone Action Pathway;Levobunolol Action Pathway;Metipranolol Action Pathway;Mexiletine Action Pathway;Lidocaine (Antiarrhythmic) Action Pathway;Quinidine Action Pathway;Sotalol Action Pathway;Epinephrine Action Pathway;Betaxolol Action Pathway;Atenolol Action Pathway;Alprenolol Action Pathway;Acebutolol Action Pathway;Muscle/Heart Contraction;Diltiazem Action Pathway;Propranolol Action Pathway;Pindolol Action Pathway;Penbutolol Action Pathway;Oxprenolol Action Pathway;Metoprolol Action Pathway;Esmolol Action Pathway;Bisoprolol Action Pathway;Bupranolol Action Pathway;Nebivolol Action Pathway;Amlodipine Action Pathway;Verapamil Action Pathway;Nitrendipine Action Pathway;Nisoldipine Action Pathway;Nimodipine Action Pathway;Ibutilide Action Pathway;Tocainide Action Pathway;Flecainide Action Pathway;Isradipine Action Pathway;Nifedipine Action Pathway;Felodipine Action Pathway;Nadolol Action Pathway;Carvedilol Action Pathway;Labetalol Action Pathway;Striated Muscle Contraction;Striated Muscle Contraction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.214
- rvis_EVS
- -0.41
- rvis_percentile_EVS
- 26.23
Haploinsufficiency Scores
- pHI
- 0.307
- hipred
- Y
- hipred_score
- 0.726
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.660
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnnt3
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; growth/size/body region phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- tnnt3b
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- skeletal muscle contraction;muscle contraction;regulation of striated muscle contraction;muscle filament sliding;regulation of ATPase activity;sarcomere organization;cardiac muscle contraction
- Cellular component
- cytosol;troponin complex
- Molecular function
- actin binding;calcium ion binding;protein binding;tropomyosin binding;troponin C binding;calcium-dependent ATPase activity;troponin I binding;calcium-dependent protein binding